Phibro Animal Health Stock News

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

SAN FRANCISCO , March 4, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Animal Feed Additives - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE What''s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research Platform Complimentary updates for one year Edition: 17; Released: February 2022 Executive Pool: 8171 Companies: 272 - Players covered include ADDCON GmbH; Adisseo France SAS; Ajinomoto Co., Inc.; Alltech Inc.; Archer Daniels Midland Company; BASF SE; Cargill, Inc.; Chr. Hansen A/S; CJ CheilJedang Corp.; DelaconBiotechnik GmbH; DSM Nutritional Products; Eastman Chemical Company; Elanco Animal Health; Evonik Industries AG; Kemin Industries, Inc.; Lonza Group Ltd.; METEX NØØVISTAGO; Novozymes A/S; Novus International, Inc.; Nutreco N.V.; Pancosma SA; Phibro Animal Health Corporation; Provimi Holding B.V.; The Mosaic Company; Zoetis, Inc. and Others.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Phibro's (PAHC) stock rallies on continued demand for its products globally and raised 2022 guidance.

Phibro's (PAHC) stock rallies on continued demand for its products globally and raised 2022 guidance.

Per the exclusive agreement, Phirbo (PAHC) together with Dyadic will continue development work to find a vaccine candidate using Dyadic's C1 cells.

Stocks with rising P/E often proves to be an intriguing investing idea.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Stocks with rising P/E often proves to be an intriguing investing idea.

Phibro (PAHC) reports better-than-expected earnings for the fiscal second quarter. Robust performances by the Animal Health and Mineral Health segments drove the top line.

Phibro (PAHC) reports better-than-expected earnings for the fiscal second quarter. Robust performances by the Animal Health and Mineral Health segments drove the top line.